A innovative medication, Retatrutide , is creating considerable buzz amongst clinicians and people in Australia dealing with weight challenges. Developed by a pharmaceutical firm, Retatrutide works as a dual GIP and GLP-1 receptor-based agonist, showing significant potential to aid body fat reduc